Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Bully88on Apr 12, 2021 12:23pm
110 Views
Post# 32977755

RE:New Investor Intel article

RE:New Investor Intel articleThanks for posting this real Jonny.

I truely believe that this aquisition was a smart move as being able to provide the whole scope of cancer treatment gives them an edge when marketing Aristotle.

Still think that the way it was released was a little amateurish but I believe in the overall product and still belive this company to be a future major revenue producer.

Lets see where they can take it from here.

Very excited for news to come in the near future that will provide clarity on their new business.

Could price drop lower short term? . yes.

will Aristotle still succeed? Yes.

There are so many questions still yet to be answered.

what we do know is their new aquisition gives them access to 3000 "clients/Patients"

Tests Completed Price for test Total revenue
1  $ 1,500.00  $           1,500.00
2  $ 1,500.00  $           3,000.00
3  $ 1,500.00  $           4,500.00
4  $ 1,500.00  $           6,000.00
5  $ 1,500.00  $           7,500.00
6  $ 1,500.00  $           9,000.00
7  $ 1,500.00  $        10,500.00
8  $ 1,500.00  $        12,000.00
9  $ 1,500.00  $        13,500.00
10  $ 1,500.00  $        15,000.00
11  $ 1,500.00  $        16,500.00
12  $ 1,500.00  $        18,000.00
13  $ 1,500.00  $        19,500.00
14  $ 1,500.00  $        21,000.00
15  $ 1,500.00  $        22,500.00
16  $ 1,500.00  $        24,000.00
17  $ 1,500.00  $        25,500.00
18  $ 1,500.00  $        27,000.00
19  $ 1,500.00  $        28,500.00
20  $ 1,500.00  $        30,000.00
21  $ 1,500.00  $        31,500.00
22  $ 1,500.00  $        33,000.00
23  $ 1,500.00  $        34,500.00
24  $ 1,500.00  $        36,000.00
25  $ 1,500.00  $        37,500.00
26  $ 1,500.00  $        39,000.00
27  $ 1,500.00  $        40,500.00
28  $ 1,500.00  $        42,000.00
29  $ 1,500.00  $        43,500.00
30  $ 1,500.00  $        45,000.00
31  $ 1,500.00  $        46,500.00
32  $ 1,500.00  $        48,000.00
33  $ 1,500.00  $        49,500.00
34  $ 1,500.00  $        51,000.00
35  $ 1,500.00  $        52,500.00
36  $ 1,500.00  $        54,000.00
37  $ 1,500.00  $        55,500.00
38  $ 1,500.00  $        57,000.00
39  $ 1,500.00  $        58,500.00
40  $ 1,500.00  $        60,000.00
41  $ 1,500.00  $        61,500.00
42  $ 1,500.00  $        63,000.00
43  $ 1,500.00  $        64,500.00
44  $ 1,500.00  $        66,000.00
45  $ 1,500.00  $        67,500.00
46  $ 1,500.00  $        69,000.00
47  $ 1,500.00  $        70,500.00
48  $ 1,500.00  $        72,000.00
49  $ 1,500.00  $        73,500.00
50  $ 1,500.00  $        75,000.00
51  $ 1,500.00  $        76,500.00
52  $ 1,500.00  $        78,000.00
53  $ 1,500.00  $        79,500.00
54  $ 1,500.00  $        81,000.00
55  $ 1,500.00  $        82,500.00
56  $ 1,500.00  $        84,000.00
57  $ 1,500.00  $        85,500.00
58  $ 1,500.00  $        87,000.00
59  $ 1,500.00  $        88,500.00
60  $ 1,500.00  $        90,000.00
61  $ 1,500.00  $        91,500.00
62  $ 1,500.00  $        93,000.00
63  $ 1,500.00  $        94,500.00
64  $ 1,500.00  $        96,000.00
65  $ 1,500.00  $        97,500.00
66  $ 1,500.00  $        99,000.00
67  $ 1,500.00  $      100,500.00
68  $ 1,500.00  $      102,000.00
69  $ 1,500.00  $      103,500.00
70  $ 1,500.00  $      105,000.00
71  $ 1,500.00  $      106,500.00
72  $ 1,500.00  $      108,000.00
73  $ 1,500.00  $      109,500.00
74  $ 1,500.00  $      111,000.00
75  $ 1,500.00  $      112,500.00
76  $ 1,500.00  $      114,000.00
77  $ 1,500.00  $      115,500.00
78  $ 1,500.00  $      117,000.00
79  $ 1,500.00  $      118,500.00
80  $ 1,500.00  $      120,000.00
81  $ 1,500.00  $      121,500.00
82  $ 1,500.00  $      123,000.00
83  $ 1,500.00  $      124,500.00
84  $ 1,500.00  $      126,000.00
85  $ 1,500.00  $      127,500.00
86  $ 1,500.00  $      129,000.00
87  $ 1,500.00  $      130,500.00
88  $ 1,500.00  $      132,000.00
89  $ 1,500.00  $      133,500.00
90  $ 1,500.00  $      135,000.00
91  $ 1,500.00  $      136,500.00
92  $ 1,500.00  $      138,000.00
93  $ 1,500.00  $      139,500.00
94  $ 1,500.00  $      141,000.00
95  $ 1,500.00  $      142,500.00
96  $ 1,500.00  $      144,000.00
97  $ 1,500.00  $      145,500.00
98  $ 1,500.00  $      147,000.00
99  $ 1,500.00  $      148,500.00
100  $ 1,500.00  $      150,000.00
200  $ 1,500.00  $      300,000.00
300  $ 1,500.00  $      450,000.00
400  $ 1,500.00  $      600,000.00
500  $ 1,500.00  $      750,000.00
600  $ 1,500.00  $      900,000.00
700  $ 1,500.00  $   1,050,000.00
800  $ 1,500.00  $   1,200,000.00
900  $ 1,500.00  $   1,350,000.00
1000  $ 1,500.00  $   1,500,000.00
1500  $ 1,500.00  $   2,250,000.00
2000  $ 1,500.00  $   3,000,000.00
2500  $ 1,500.00  $   3,750,000.00
3000  $ 1,500.00  $   4,500,000.00


For a company to come from making no money to being able to make potentially $4,500,000 in a year (assuming that everyone of those patients will take an aristotle test once during treatment)  is amazing.

On top of that, we will be able to use our new "clients/patients" to further validate Aristotle. Which will be a  Major Milestone to achieve

We may have set ourselve back a year in terms of share price, but we have improved our overall fundamental business by leaps and bounds.

Very frustrated with how it was handled, as we could be sitting at our ATH if it was done differently, but I still believe that we will be a major force in the Cancer Testing game.

Cheers all,

Bully





<< Previous
Bullboard Posts
Next >>